论文部分内容阅读
目的:探讨分析用高通量血液透析联合血液灌流治疗老年肾性骨病的临床效果。方法 :选取2014年2月至2015年2月间我院收治的老年肾性骨病患者60例作为研究对象,采用随机数表法将其分为对照组(30例)和观察组(30例),为对照组患者进行常规的维持性血液透析治疗,为观察组患者进行高通量血液透析治疗联合血液灌流治疗,然后观察对比两组患者的临床疗效,并将对比的结果及两组患者的临床资料进行回顾性的分析。结果 :观察组患者病情的缓解率为80.00%,对照组患者病情的缓解率为30.00%,观察组患者的临床疗效明显优于对照组患者,差异显著(P<0.05),具有统计学意义。观察组患者甲状旁腺激素的水平为(534.55±97.34)pg/ml,对照组患者甲状旁腺激素的水平为(463.39±100.22)pg/mg,观察组患者甲状旁腺激素的水平明显高于对照组患者,差异显著(P<0.05),具有统计学意义。结论 :用高通量血液透析联合血液灌流治疗老年肾性骨病的临床效果显著,值得在临床上推广应用。
Objective: To investigate the clinical effect of high-flux hemodialysis combined with hemoperfusion on senile renal osteodystrophy. Methods: Sixty patients with senile renal osteodystrosis admitted to our hospital from February 2014 to February 2015 were selected as the research object. The patients were divided into control group (30 cases) and observation group (30 cases ) For the control group of patients with routine maintenance hemodialysis treatment for the observation group patients with high-throughput hemodialysis combined with hemoperfusion treatment, and then observed and compared the clinical efficacy of the two groups of patients, and the results of the comparison and two groups of patients The clinical data were retrospectively analyzed. Results: The remission rate was 80.00% in the observation group and 30.00% in the control group. The clinical efficacy of the observation group was significantly better than that of the control group (P <0.05), with statistical significance. The level of parathyroid hormone in the observation group was (534.55 ± 97.34) pg / ml, and the level of parathyroid hormone in the control group was (463.39 ± 100.22) pg / mg. The level of parathyroid hormone in the observation group was significantly higher than that in the observation group Control group patients, the difference was significant (P <0.05), with statistical significance. Conclusion: High-throughput hemodialysis combined with hemoperfusion for the treatment of senile renal osteopathy has a significant clinical effect and is worth popularizing in clinic.